NRNextRounds

SV Biotech Crossover Opportunities Fund LP

London, X0

SEC Form D ↗

Amount Raised

$135.2M

Target Size

$350.0M

Investors

7

Date Filed

2022-01-18

Dry powder breakdown

Est. Remaining

Fully deployed

Deployed

$135.2M

100% deployedVintage ≥ 4 years

Raised 39% of $350.0M target

Filing details

Fund vehicleSV Biotech Crossover Opportunities Fund LP
IndustryVenture Capital Fund
Address71 KINGSWAY, LONDON, X0
Phone44 20 7421 7081
Related personsView on SEC EDGAR ↗